Edition:
United Kingdom

Viking Therapeutics Inc (VKTX.OQ)

VKTX.OQ on NASDAQ Stock Exchange Capital Market

18.97USD
20 Sep 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$18.97
Open
--
Day's High
--
Day's Low
--
Volume
10,855
Avg. Vol
850,280
52-wk High
$24.00
52-wk Low
$1.21

Select another date:

Tue, Sep 18 2018

Viking shares surge after fatty liver drug trial

Viking Therapeutics Inc's shares more than doubled in value on Tuesday after promising data from a mid-stage trial of its fatty liver drug were seen as topping that from larger rival Madrigal Pharmaceuticals .

UPDATE 1-Viking shares soar as liver disease drug succeeds in mid-stage study

Sept 18 Viking Therapeutics Inc's shares more than doubled on Tuesday after its experimental liver disease treatment met the goals of a mid-stage trial by lowering cholesterol and liver fat levels in patients.

Viking Therapeutics liver drug succeeds in mid-stage study

Sept 18 Viking Therapeutics Inc said on Tuesday its experimental liver disease treatment met the main goals of a mid-stage trial by reducing cholesterol and liver fat in patients.

BRIEF-Viking Therapeutics Q1 Loss Per Share $0.08

* VIKING THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Select another date: